News

Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the US Food and Drug Administration (FDA) for chronic ...
GSK’s Blenrep is the only B-cell maturation antigen (BCMA)-targeted antibody-drug conjugate for multiple myeloma, offering ...
The US Food and Drug Administration (FDA) has approved a pre-filled syringe version of argenx’s Vyvgart, giving generalised ...
Happy families In his book ‘Anna Karenina’, Tolstoy describes how every happy family is happy in the same way, but every ...
The countdown is on! The Medscape team is heading to San Diego for this year’s highly anticipated Digestive Disease Week (DDW ...
Want to truly engage and educate HCPs? Learn to avoid costly mistakes and be at the forefront of learning by creating a ...
Uniphar, a global leader in pharmaceutical and medtech solutions has announced the launch of its 10th cell and gene therapy ...
GSK’s five-in-one meningococcal vaccine has been recommended by the US Centers for Disease Control and Prevention’s (CDC) ...
LEO Pharma and the Parker Institute at Copenhagen University Hospital have entered into a three-year academic partnership aimed at advancing dermatology research. The alliance will focus on enhancing ...
The US Food and Drug Administration (FDA) has designated Celltrion’s Yuflyma (adalimumab-aaty) as an interchangeable biosimilar to AbbVie’s Humira (adalimumab). The decision allows Yuflyma to be ...